Global Information
회사소개 | 문의 | 비교리스트

세계의 초붕괴제 시장 규모 조사 : 종류별, 제제별, 치료 분야별, 지역별

Global Superdisintegrants Market Size study, by Type, Formulation, Therapeutic Area and Regional Forecasts 2019-2026

리서치사 Bizwit Research & Consulting LLP
발행일 2019년 05월 상품 코드 871549
페이지 정보 영문
가격
US $ 4,950 ₩ 5,974,000 Unprintable PDF (Single User License)
US $ 6,250 ₩ 7,543,000 Printable PDF (Enterprise License)


세계의 초붕괴제 시장 규모 조사 : 종류별, 제제별, 치료 분야별, 지역별 Global Superdisintegrants Market Size study, by Type, Formulation, Therapeutic Area and Regional Forecasts 2019-2026
발행일 : 2019년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 초붕괴제(Superdisintegrants) 시장에 대해 조사했으며, 종류·제제·치료 분야·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리했습니다.

목차

제1장 주요 요약

  • 시장 현황
  • 주요 동향
  • 전체 및 부문별 시장 예측
    • 종류별
    • 제제별
    • 치료 분야별
    • 지역별
  • 조사 방법
  • 조사 가정

제2장 초붕괴제 시장 정의와 범위

  • 연구 목적
  • 시장 정의와 범위
    • 산업 진화
    • 조사 범위
  • 조사 대상 기간
  • 통화 환산율

제3장 초붕괴제 시장 역학

  • See Saw 분석
    • 시장 성장 촉진요인
    • 시장 과제
    • 시장 기회

제4장 초붕괴제 시장 업계 분석

  • Porter's Five Forces 분석
    • 구매자의 협상력
    • 공급업체의 협상력
    • 신규 참여업체의 위협
    • 대용품의 위협
    • 업계내의 경쟁
    • Porter's Five Forces 분석에 대한 미래적 접근
  • PEST 분석
    • 정치
    • 경제
    • 사회
    • 기술
  • 주요 구입 기준
  • 규제 체계
  • 투자/도입 시나리오
  • 애널리스트의 제안과 결론

제5장 종류별 : 초붕괴제 시장

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 참여 기업
  • 초붕괴제 시장, 하위 부문 분석
    • 천연 초붕괴제
    • 합성 초붕괴제
    • 기타 초붕괴제

제6장 제제별 : 초붕괴제 시장

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 참여 기업
  • 초붕괴제 시장, 하위 부문 분석
    • 캡슐
    • 정제

제7장 치료 분야별 : 초붕괴제 시장

  • 시장 현황
  • 시장 실적 - 잠재적인 모델
  • 주요 시장 참여 기업
  • 초붕괴제 시장, 하위 부문 분석
    • 소화기 질환
    • 신경 질환
    • 염증성 질환
    • 종양학
    • 심혈관 질환
    • 감염증
    • 혈액 질환

제8장 지역별 : 초붕괴제 시장

  • 초붕괴제 시장, 지역 시장 현황
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 기타 유럽 지역
  • 아시아
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양 지역
  • 라틴아메리카
    • 브라질
    • 멕시코
  • 기타 세계 지역
    • 남미
    • 중동 및 아프리카

제9장 경쟁 상황

  • 기업의 시장 점유율(데이터 입수 가능성별)
  • 주요 시장 전략
  • 기업 개요
    • Ashland Global Holdings Inc.
    • BASF SE
    • DowDuPont Inc.
    • Roquette Freres
    • DFE Pharma
    • JRS Pharma
    • Asahi Kasei Corporation
    • Merck KGaA
    • Corel Pharma Chem
    • Avantor Performance Materials, LLC

제10장 조사 방법

  • 조사 방법
    • 데이터마이닝
    • 분석
    • 시장 예측
    • 검증
    • 출판
    • 조사 가정
KSM 19.07.04

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF SUPERDISINTEGRANTS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF SUPERDISINTEGRANTS MARKET
  • TABLE 3. SUPERDISINTEGRANTS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY FORMULATION 2016-2026 (USD BILLION)
  • TABLE 9. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY THERAPEUTIC AREA 2016-2026 (USD BILLION)
  • TABLE 10. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 29. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 30. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 32. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 33. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 35. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 36. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 38. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 39. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 41. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 42. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 44. SUPERDISINTEGRANTS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 45. SUPERDISINTEGRANTS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. U.S. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 47. U.S. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. U.S. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 49. U.S. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. U.S. SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. CANADA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. CANADA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. CANADA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. CANADA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 55. CANADA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. UK SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 57. UK SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 58. UK SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. UK SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. UK SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 61. GERMANY SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 62. GERMANY SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. GERMANY SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 64. GERMANY SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. GERMANY SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 66. ROE SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 67. ROE SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 68. ROE SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 69. ROE SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 70. ROE SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 71. CHINA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 72. CHINA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 73. CHINA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 74. CHINA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 75. CHINA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 76. INDIA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 77. INDIA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 78. INDIA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 79. INDIA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 80. INDIA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 81. JAPAN SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 82. JAPAN SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 83. JAPAN SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 84. JAPAN SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 85. JAPAN SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 86. ROAPAC SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 87. ROAPAC SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 88. ROAPAC SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 89. ROAPAC SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 90. ROAPAC SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 91. BRAZIL SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 92. BRAZIL SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 93. BRAZIL SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 94. BRAZIL SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 95. BRAZIL SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 96. MEXICO SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 97. MEXICO SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 98. MEXICO SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 99. MEXICO SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 100. MEXICO SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 101. ROLA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 102. ROLA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 103. ROLA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 104. ROLA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 105. ROLA SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 106. ROW SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 107. ROW SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 108. ROW SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 109. ROW SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 110. ROW SUPERDISINTEGRANTS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. SUPERDISINTEGRANTS MARKET, RESEARCH METHODOLOGY
  • FIG 2. SUPERDISINTEGRANTS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. SUPERDISINTEGRANTS MARKET, KEY TRENDS 2017
  • FIG 5. SUPERDISINTEGRANTS MARKET, GROWTH PROSPECTS 2018-2026
  • FIG 6. SUPERDISINTEGRANTS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. SUPERDISINTEGRANTS MARKET, PEST ANALYSIS
  • FIG 8. SUPERDISINTEGRANTS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 19. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 20. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 21. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 22. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 23. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 24. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 25. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 26. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 27. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 28. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 29. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 30. SUPERDISINTEGRANTS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 31. SUPERDISINTEGRANTS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 32. NORTH AMERICA SUPERDISINTEGRANTS MARKET 2016 & 2026 (USD BILLION)
  • FIG 33. EUROPE SUPERDISINTEGRANTS MARKET 2016 & 2026 (USD BILLION)
  • FIG 34. ASIA PACIFIC SUPERDISINTEGRANTS MARKET 2016 & 2026 (USD BILLION)
  • FIG 35. LATIN AMERICA SUPERDISINTEGRANTS MARKET 2016 & 2026 (USD BILLION)
  • FIG 36. SUPERDISINTEGRANTS MARKET, COMPANY MARKET SHARE ANALYSIS (2017)

Global superdisintegrants market is valued at approximately USD 349.60 million in 2018 and is anticipated to grow with a healthy growth rate of more than 8.10% over the forecast period 2019-2026. Superdisintegrants are combination of substances added to drug formulation that accelerates the disintegration of capsule content or tablets into smaller particles which easily gets dissolved. Increasing adoption of oral disintegrating tablets is one of the major driving factors of global superdisintegrants market. In addition, shifting focus of pharmaceutical manufacturers towards emerging markets is an added advantage for the growth of market. However, less expenditure in R&D activities restricts the market to grow with the expected rate. For instance, the fragmentation of the EU pharmaceutical market resulted in lucrative parallel trade. Neither social security nor patients are benefitted with this and leads to deprival of additional resources for funding R&D.

The regional analysis of global Superdisintegrants market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to rising adoption of synthetic superdisintegrants. Europe also contributes a satisfactory growth in the global Superdisintegrants market due to rising population affected by neurological diseases. Asia-Pacific is also anticipated to exhibit higher growth rate / CAGR over the forecast period 2019-2026 due to increasing preference to ODTs in developing countries such as India China and Japan.

The leading market player included in this report are:

  • BASF SE
  • DowDuPont Inc.
  • Roquette Freres
  • DFE Pharma
  • JRS Pharma
  • Asahi Kasei Corporation
  • Merck KGaA
  • Corel Pharma Chem
  • Avantor Performance Materials, LLC
  • Ashland Global Holdings Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Natural
  • Synthetic
  • Others

By Formulation:

  • Tablets
  • Capsules

By Therapeutic Area:

  • Neurological Diseases
  • Gastrointestinal Diseases
  • Oncology
  • Inflammatory Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases

By Regions:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • Asia Pacific
  • China
  • India
  • Japan
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016, 2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Superdisintegrants Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
    • 1.3.1. Superdisintegrants Market, by Type, 2016-2026 (USD Billion)
    • 1.3.2. Superdisintegrants Market, by Formulation, 2016-2026 (USD Billion)
    • 1.3.3. Superdisintegrants Market, by Therapeutic Area, 2016-2026 (USD Billion)
    • 1.3.4. Superdisintegrants Market, by Region, 2016-2026 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Superdisintegrants Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Superdisintegrants Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Superdisintegrants Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Key Buying Criteria (On Demand)
  • 4.4. Regulatory Framework (On Demand)
  • 4.5. Investment Vs Adoption Scenario (On Demand)
  • 4.6. Analyst Recommendation & Conclusion

Chapter 5. Superdisintegrants Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Superdisintegrants Market, Sub Segment Analysis
    • 5.4.1. Natural Superdisintegrants
      • 5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.2. Synthetic Superdisintegrants
      • 5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 5.4.3. Other Superdisintegrants
      • 5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 6. Superdisintegrants Market, by Formulation

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Superdisintegrants Market, Sub Segment Analysis
    • 6.4.1. Capsules
      • 6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 6.4.2. Tablets
      • 6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 7. Superdisintegrants Market, by Therapeutic Area

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Superdisintegrants Market, Sub Segment Analysis
    • 7.4.1. Gastrointestinal Diseases
      • 7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.2. Neurological Diseases
      • 7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.3. Inflammatory Diseases
      • 7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.4. Oncology
      • 7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.5. Cardiovascular Diseases
      • 7.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.6. Infectious Diseases
      • 7.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 7.4.7. Hematological Diseases
      • 7.4.7.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 7.4.7.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 8. Superdisintegrants Market, by Regional Analysis

  • 8.1. Superdisintegrants Market, Regional Market Snapshot (2016-2026)
  • 8.2. North America Superdisintegrants Market Snapshot
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.1.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.2.2.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.3. Europe Superdisintegrants Market Snapshot
    • 8.3.1. U.K.
      • 8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.1.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.2.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.3.3. Rest of Europe
      • 8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.3.3.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.4. Asia Superdisintegrants Market Snapshot
    • 8.4.1. China
      • 8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.1.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.2. India
      • 8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.2.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.3.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.4.4. Rest of Asia Pacific
      • 8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.4.4.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.5. Latin America Superdisintegrants Market Snapshot
    • 8.5.1. Brazil
      • 8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.1.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.5.2. Mexico
      • 8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.5.2.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
  • 8.6. Rest of The World
    • 8.6.1. South America
      • 8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.1.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)
    • 8.6.2. Middle East and Africa
      • 8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.2. Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.3. Formulation breakdown estimates & forecasts, 2016-2026 (USD Billion)
      • 8.6.2.4. Therapeutic Area breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9. Competitive Intelligence

  • 9.1. Company Market Share (Subject to Data Availability)
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Ashland Global Holdings Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial (Subject to Data Availability)
      • 9.3.1.3. Product Summary
      • 9.3.1.4. Recent Developments
    • 9.3.2. BASF SE
    • 9.3.3. DowDuPont Inc.
    • 9.3.4. Roquette Freres
    • 9.3.5. DFE Pharma
    • 9.3.6. JRS Pharma
    • 9.3.7. Asahi Kasei Corporation
    • 9.3.8. Merck KGaA
    • 9.3.9. Corel Pharma Chem
    • 9.3.10. Avantor Performance Materials, LLC

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
    • 10.1.6. Research Assumption
Back to Top
전화 문의
F A Q